Topics
Background Hepatitis Transmission Standard Precautions Testing Natural History Symptoms Treatment Disclosure / Discrimination Contacts
Hepatitis
Hepatitis means inflammation of the liver Alcohol, chemicals, autoimmune disease, drugs and a number of viruses can lead to hepatitis 6 known hepatitis viruses: A, B, C, D, E & G - Different modes of transmission, effects on the body & treatments
A..B..C..D..E.. ..G !!
A Faecal-oral route B Blood and body fluids C Blood-to-blood D Blood and body fluids E Faecal-oral route G Blood-to-blood
Background-Hepatitis C
Hepatitis C - in existence for a long time First named non-A, non-B hepatitis in 1973 and hepatitis C in 1989 Antibody testing commenced 1990
In Australia thats approximately a bus load of people each day (approx 40) newly infected with hepatitis C
Principles of Transmission
Hepatitis C virus must exit the body Hepatitis C virus must survive in the environment in which it has been placed Sufficient concentration of virus (viral load) must be present to cause infection Hepatitis C virus must enter the bloodstream of another person
Transmission
Hepatitis C and injecting drug use:
Approx 90% of new infections due to the sharing and reusing of injecting drug equipment Not just about the syringe - all equipment used for injecting can facilitate transmission
Transmission
Blood transfusion or blood products before 1990 Place of birth (eg.Mediterranean; South East Asia) History of imprisonment Unsterile tattooing or body piercing Occupational transmission needlestick injury (2% - 10% risk)
Transmission
Mother to baby (during pregnancy or at birth - 5% - 8% risk) Risk increased if hepatitis C contracted during pregnancy HIV co-infection increases risk 4-fold Sharing personal grooming items (razors, toothbrushes ) Fighting Breach of standard precautions unsterile medical procedures
Who Is Affected
Of infections in Australia:
83% were a result of injecting drugs 5% were a result of receiving blood transfusions or blood products prior to 1990 12% were a result of other factors - high prevalence country of birth, vertical transmission, unsterile tattooing
Hepatitis C Virus Projections Working Group - Estimates and Projections of the Hepatitis C Virus Epidemic in Australia 2002 -ANCAHRD Hepatitis C Sub-Committee
Who is at Risk
Young People
Diagnosis among 15 -19 year olds doubled from 1996 2001
(NCHECR - Annual Surveillance Report 2001)
People in Prison
40% of males and 65% of women are estimated to have hepatitis C (Butler, T, Inmate Health Survey 2002)
Indigenous People
In 2000, 10% of new diagnoses were Aboriginal and Torres Strait Islander where ethnicity recorded (NCHECR 2001)
Correct application of Standard Precautions break the links in the chain of infection, preventing the transmission of Hepatitis C Standard precautions allow HCWs to provide care to all patients safely and without discrimination
(Previous presentations: Sue Gore and Christine Hunt)
Standard Precautions
Hand Hygiene Use of Personal Protective Equipment (PPEs) Waste Management Care with sharps Reprocessing of Equipment Environmental Controls Routine preoperative testing of patients is not recommended
Testing
Antibody test Window period 2 weeks up to 6 months, but on average 6 to 12 weeks. Indicates a person has been exposed to the virus. Doesnt determine if infection is current or what genotype is present PCR tests Qualitative virus detected/not detected Quantitative viral load Genotype
Natural History
O f 1 0 0 p e o p le w it h c h r o n ic h e p a t it is C w h o r e m a in u n t r e a t e d a f t e r 2 0 ye a r s
1% 7% m a y d e v e lo p m a y d e v e lo p liv e r f a ilu r e o r c ir r h o s is cancer 47% m ay 45% d e v e lo p m ild t o m a y ne ve r m o d e r a te d e v e lo p s e r io u s liv e r d a m a g e liv e r d a m a g e
Natural History
O f 1 0 0 p e o p le w ith c h r o n ic h e p a titis C w h o r e m a in u n t r e a t e d a f t e r 4 0 ye a r s
4% m ay d e v e lo p liv e r 20% f a ilu r e o r m a y d e v e lo p c a n c e r c ir r h o s is 31% m ay d e v e lo p m ild t o m o d e r a te liv e r d a m a g e
45% m a y n e ve r d e v e lo p s e r io u s liv e r d a m a g e
Hepatitis C Treatment ?
Combination Therapy (pegylated interferon and ribavirin) Treatment Regime weekly self administered injections of pegylated interferon & daily ribavirin tablets taken orally Treatment adherence is critical to achieve sustained viral response (SVR) 6 months 12 months (depending on genotype / cirrhosis) Overall across genotypes, 60% viral clearance and up to 80% viral clearance in genotype 2 & 3
Disclosure
Only people with hepatitis C who are working with exposure prone procedures are required to disclose their hepatitis C status All other people with hepatitis C are not required to disclose their hepatitis C status (exceptions on insurance forms, to blood banks,on armed forces applications)
Social Implications
Social Stigma Discrimination Family Fear Isolation Poverty Impact on health and well-being
Useful Websites
Hepatitis C Council of SA http://www.hepccouncilsa.asn.au Australian Hepatitis Council http://www.hepatitisaustralia.com Australian Society for HIV Medicine (ASHM) http://www.ashm.org.au National Hepatitis C Resource Manual http://www.health.gov.au/internet/wcms/publishing.nsf/Conten health-pubhlth-strateg-hiv_hepc-hepc-manual.htm National Hepatitis C Treatment Awareness Week http://www.hepcawareness.net.au
Contact Details
Hepatitis C Council of South Australia Inc. 8362 8443, (Free Call Rural SA 1800 02 11 33) Hepatitis Helpline 1800 621 780 Mosaic Counseling - 8223 4566 / 1800 182 325 SAVIVE - 8362 9299 Aboriginal Drug and Alcohol Council SA - 8362 0395 PEACE Project - Service for CALD communities 8245 8100 Clinic 275 - 8226 6025 / 1800 80 64 90